Nimbex and Buscopan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nimbex (cisatracurium besylate) and Buscopan (hyoscine butylbromide). Common drug interactions include anaphylactic reaction among males.

The phase IV clinical study analyzes what interactions people have when they take Nimbex and Buscopan. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Nimbex?

Nimbex has active ingredients of cisatracurium besylate. eHealthMe is studying from 1,546 Nimbex users. Check the latest studies of Nimbex.

What is Buscopan?

Buscopan has active ingredients of hyoscine butylbromide. eHealthMe is studying from 4,828 Buscopan users. Check the latest studies of Buscopan.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

13 people who take Nimbex and Buscopan together, and have interactions are studied.

What are the common drug interactions of Nimbex and Buscopan, by gender? *:

female:

n/a

male:

Anaphylactic reaction (serious allergic reaction)
Erythema (redness of the skin)
Hypoxia (low oxygen in tissues)
Respiratory distress (difficulty in breathing)
Hypotension (abnormally low blood pressure)
Periorbital oedema (swelling around the eyes)
Alveolitis (inflammation in the socket of a tooth)
Anaphylactoid reaction (type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation)
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Cough

What are the common drug interactions of Nimbex and Buscopan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Hypoxia (low oxygen in tissues)
Respiratory distress (difficulty in breathing)
Alveolitis (inflammation in the socket of a tooth)
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Cough
Dyspnoea (difficult or laboured respiration)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Anaphylactic reaction (serious allergic reaction)
Erythema (redness of the skin)
Hypotension (abnormally low blood pressure)
Periorbital oedema (swelling around the eyes)
Anaphylactoid reaction (type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation)

What are the existing conditions these people have? *

Pain: 13 people, 100.00%
Anaesthesia: 13 people, 100.00%
Type 2 Diabetes: 12 people, 92.31%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 12 people, 92.31%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 12 people, 92.31%
High Blood Pressure: 12 people, 92.31%
General Anaesthesia: 12 people, 92.31%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 92.31%
Infection: 6 people, 46.15%
Oesophagitis (inflammation of oesophagus): 4 people, 30.77%

* Approximation only. Some reports may have incomplete information.

Do you take Nimbex and Buscopan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously